Position in GANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$72,714
+$3,224 QoQ
Shares Held
35,820
0.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 49 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. GANX ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 | |
| 8 | CGON |
CG Oncology, Inc.
|
10,811 | $768,121 |
All Filings in GANX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,714 | 35,820 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $69,490 | 35,820 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $115,340 | 35,820 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $63,401 | 35,820 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $64,476 | 35,820 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $68,416 | 35,820 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $77,371 | 35,820 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $63,759 | 35,820 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $45,849 | 35,820 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $135,041 | 35,820 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $189,696 | 58,100 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $190,568 | 58,100 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $260,288 | 58,100 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $280,042 | 58,100 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $181,853 | 58,100 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $189,406 | 58,100 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $209,160 | 58,100 | Shares | Other | 2022-08-24 | |
| 2022-03-31 | $237,629 | 58,100 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $315,483 | 58,100 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $432,554 | 58,100 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $581,000 | 58,100 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $866,852 | 58,100 | Shares | Other | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||